Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data2026 · 3 citations
2. 2Signal Detection and Temporal Analysis of Aromatase Inhibitor‐Associated Hepatotoxicity: A Pharmacovigilance Study Integrating Bayesian Belief‐Propagation Network and Frequentist Metrics2026
3. 3Vitreoretinal Traction Syndrome, Nitrituria and Human Epidermal Growth Factor Receptor Negative Might Occur in the Aromatase-Inhibitor Anastrozole Treatment2024 · 13 citations
4. 4Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report2025 · 1 citations
5. 5Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the <scp>FDA</scp> Adverse Event Reporting System2024 · 8 citations